Skip to main content
Year archive

INVERT GRAPHITE LIMITED — 2018 filings

All 57 regulatory filings released by INVERT GRAPHITE LIMITED (IVG) in 2018, sourced directly from the official regulator.

57 Filings
2018 Period
2018 filings (57)
Filing Released Lang
Change to Board Composition 1 page 86.7KB
Regulatory Filings
2018-12-11 English
Appendix 3Z - Dr Robert Ryan 2 pages 78.4KB
Regulatory Filings
2018-12-11 English
Shareholder Update - Frequently Asked Questions 5 pages 213.8KB
Regulatory Filings
2018-11-21 English
Ceasing to be a substantial holder - Revised 2 pages 456.6KB
Regulatory Filings
2018-11-20 English
Ceasing to be a substantial holder 2 pages 456.4KB
Regulatory Filings
2018-11-19 English
Ceasing to be a substantial holder 4 pages 144.3KB
Regulatory Filings
2018-11-15 English
Results of Phase 2 Clinical Trial 3 pages 243.2KB
Regulatory Filings
2018-11-13 English
Conference Call Details - Phase 2 Clinical Trial Results 16 pages 1.5MB
Regulatory Filings
2018-11-13 English
Trading Halt 2 pages 180.2KB
Regulatory Filings
2018-11-12 English
Appendix 4C - September 2018 Quarter 6 pages 172.5KB
Regulatory Filings
2018-10-18 English
Factor Therapeutics Appoints Transaction Advisor 1
Regulatory Filings
2018-10-15 English
Last patient completes treatment in VLU Ph 2 Clinical Trial 1
Regulatory Filings
2018-10-03 English
Shareholder Update Q3 2018 4 pages 277.8KB
Regulatory Filings
2018-10-01 English
Phase 2 Trial for Venous Leg Ulcers Nears Completion 1
Regulatory Filings
2018-09-05 English
Half Yearly Report and Accounts 16 pages 1.0MB
Regulatory Filings
2018-08-22 English
CEO presentation to Broker Meets Biotech - Perth 17 pages 6.2MB
Regulatory Filings
2018-08-15 English
CEO Presentation to Bioshares Conference 13 pages 10.4MB
Regulatory Filings
2018-07-26 English
Appendix 4C - June 2018 quarter 6 pages 138.8KB
Regulatory Filings
2018-07-26 English
Recruitment complete in VF00102 Phase 2 clinical trial 1
Regulatory Filings
2018-07-15 English
Screening to close as clinical trial nears completion 1
Regulatory Filings
2018-06-25 English
Clinical Trial Update 1 page 239.7KB
Regulatory Filings
2018-06-13 English
Chairman and CEO Address to Annual General Meeting 17 pages 3.2MB
Regulatory Filings
2018-05-23 English
AGM Results of Meeting 2 pages 101.6KB
Regulatory Filings
2018-05-23 English
Receipt of $1.23M R&D tax incentive 2 pages 112.5KB
Regulatory Filings
2018-05-14 English
Clinical trial update - recruitment enters final phase 2 pages 113.4KB
Regulatory Filings
2018-05-13 English
Ceasing to be a substantial holder 2 pages 58.0KB
Regulatory Filings
2018-05-03 English
Appendix 4C - March 2018 Quarter 6 pages 157.7KB
Regulatory Filings
2018-04-25 English
Appendix 3Y - J Michailidis 2 pages 54.3KB
Regulatory Filings
2018-04-23 English
Appendix 3Y - C Hirst 2 pages 103.4KB
Regulatory Filings
2018-04-23 English
Appendix 3Y - C Behrenbruch 2 pages 106.6KB
Regulatory Filings
2018-04-23 English
Change in substantial holding 4 pages 125.1KB
Regulatory Filings
2018-04-22 English
Notice of Annual General Meeting/Proxy Form 18 pages 410.0KB
Regulatory Filings
2018-04-19 English
Appendix 3B - allotment of Rights Issue shares complete 13 pages 157.3KB
Regulatory Filings
2018-04-18 English
Completion of entitlement offer 2 pages 106.5KB
Regulatory Filings
2018-04-12 English
Clinical Trial update - March quarter 2 pages 97.6KB
Regulatory Filings
2018-04-09 English
Annual Report for transitional period to 31 December 2017 51 pages 1.0MB
Regulatory Filings
2018-03-21 English
Corporate Governance Statement to 31 December 2017 10 pages 202.6KB
Regulatory Filings
2018-03-21 English
Appendix 4G for transitional period to 31 December 2017 12 pages 202.8KB
Regulatory Filings
2018-03-21 English
Notice of despatch of Rights Issue documents 2 pages 106.1KB
Regulatory Filings
2018-03-21 English
Rights Issue Entitlement Offer - Cleansing Notice 2 pages 112.6KB
Regulatory Filings
2018-03-13 English
Investor Presentation 23 pages 1.1MB
Regulatory Filings
2018-03-13 English
Factor announces fully underwritten entitlement offer 3 pages 101.2KB
Regulatory Filings
2018-03-13 English
Rights Issue Entitlement Offer Information Booklet 38 pages 3.1MB
Regulatory Filings
2018-03-13 English
Appendix 3B - Rights Issue Entitlement Offer 13 pages 157.8KB
Regulatory Filings
2018-03-13 English
Rights Issue - Letter to eligible holders 4 pages 178.4KB
Regulatory Filings
2018-03-13 English
Rights Issue - Letter to ineligible holders 3 pages 160.3KB
Regulatory Filings
2018-03-13 English
Rights Issue - Letter to option holders 2 pages 146.6KB
Regulatory Filings
2018-03-13 English
Appendix 3B Rights Issue shares - correction to issue date 13 pages 158.8KB
Regulatory Filings
2018-03-13 English
Trading Halt 2 pages 221.5KB
Regulatory Filings
2018-03-11 English
Clinical Trial Update 4 pages 205.5KB
Regulatory Filings
2018-03-04 English
Appendix 4E Preliminary Final Report 10 pages 135.8KB
Regulatory Filings
2018-02-21 English
One-hundredth patient recruited in VF001002 clinical trial 1
Regulatory Filings
2018-02-07 English
Appendix 4C - December 2017 Quarter 6 pages 106.7KB
Regulatory Filings
2018-01-24 English
Change in financial year end 1 page 48.7KB
Regulatory Filings
2018-01-22 English
Clinical Trial Update 8 pages 7.4MB
Regulatory Filings
2018-01-17 English
Shareholder Update 4 pages 464.5KB
Regulatory Filings
2018-01-14 English
Change in substantial holding 3 pages 162.0KB
Regulatory Filings
2018-01-09 English